JPRN-jRCTs041200072
Active, not recruiting
Phase 2
COVID-19 Prevention of worsening of symptoms in asymptomatic to mild patients by combined use of kakkonto and hochuekkito:Exploratory open-label randomized controlled trial - HKCOV
Ogawa Keiko0 sites100 target enrollmentDecember 10, 2020
ConditionsCOVID-19
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Ogawa Keiko
- Enrollment
- 100
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) SARS\-CoV\-2 is positive in nucleic acid detection or antigen test.
- •2\) 20years old or over
- •3\) Asymptomatic or mild symptoms.
Exclusion Criteria
- •1\) Administration of kampo medicine (Juzendaihoto,Ninjinyoueito, Hochuekkito, Seishoekkito, Rikkunshito, Shikunshito, Kihito, Kamikihito) within the last two weeks
- •2\) Persons with a history of hypersensitivity to Hochuekkito or Kakkonto
- •3\) Those who participated in other clinical intervention studies (studies) within 3 months before the start of study drug administration
- •4\) A person who is judged by the principal investigator or the investigator to be inappropriate as a research subject.
- •5\) Those who are pregnant, may be pregnant, or are breastfeeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
High dose Vitamin D in Preventing Aggravation of COVID-19SARS-COV-2 positive patientsMedDRA version: 23.0Level: LLTClassification code 10084382Term: Coronavirus disease 2019System Organ Class: 100000004862MedDRA version: 20.0Level: PTClassification code 10050713Term: Vitamin DSystem Organ Class: 10022891 - InvestigationsMedDRA version: 20.0Level: LLTClassification code 10013097Term: Disease aggravationSystem Organ Class: 100000004867Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-001793-30-DKCopenhagen University Hospital of Bispebjerg480
Completed
Not Applicable
International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trialCOVID-19Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12620000557932AProf Dr Karin Ried446
Recruiting
Phase 1
Therapies to prevent progression of COVID-19 in outpatients: The 'Primary Care Australian COVID-19 Therapeutics' (PACT) TrialACTRN12622000386730AProf Dr Karin Ried300
Withdrawn
Not Applicable
International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial - Stage 2COVID-19Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12622000309785AProf Dr Karin Ried200
Not yet recruiting
Phase 3
Prevention and treatment for covid-19 associated severe pneumonia in The Gambia: a randomized clinical trial (PaTS-COVID) COVID-19PACTR202101544570971Medical Research Council Unit The Gambia at LSHTM1,200